# Phase I Study of Patupilone and RAD001

> **NCT00496600** · PHASE1 · COMPLETED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 42 (actual)

## Conditions studied

- Refractory Malignancy

## Interventions

- **DRUG:** Patupilone
- **DRUG:** RAD001

## Key facts

- **NCT ID:** NCT00496600
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2012-06-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496600, "Phase I Study of Patupilone and RAD001". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00496600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*